Cytotoxicity of L-cycloserine against human neuroblastoma and medulloblastoma cells is associated with the suppression of ganglioside expression

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5349-5354

  Cinatl Jr , Jindrich ^a,d   Cinatl, Jaroslav ^b   Kotchetkov, Ruslan ^b   Pouckova, Pavla ^c   Vogel, Jens Uwe ^a,b   Rabenau, Holger ^a   Michaelis, Martin ^a   Kornhuber, Bernhard ^b  

^a GOETHE UNIVERSITY   (Germany)

^b Abt Padiatrische Hamatologie O   (Germany)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

G(D2); G(M2); L cycloserine; Medulloblastoma; Neuroblastoma; Nude mice

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CYCLOSERINE; GANGLIOSIDE GD2; GANGLIOSIDE GM2;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; EPITHELIUM CELL; FEMALE; FIBROBLAST CULTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; CELLS, CULTURED; CYCLOSERINE; G(M2) GANGLIOSIDE; GANGLIOSIDES; HUMANS; MEDULLOBLASTOMA; MICE; MICE, NUDE; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0033380753     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hakamori S: Bifunctional role of glycosphingolipids: Modulator for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265: 18713-18716, 1990.
2. Hannun YA and Bell RM: Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243: 500-507, 1989.
3. Hakamori S and Igarashi Y: Gangliosides and glycosphingolipids as modulators of cell growth, adhesion and transmembrane signaling. Adv Lipid Res 25: 147-162, 1993.
4. Hakoori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56; 5309-5318, 1996.
5. Hakamori S: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52: 257-331, 1989.
6. M2 and human glioma and medulloblastoma cell lines. Cancer Res 49: 6645-6651, 1989.
7. D2 gangliosides in human cancer cell lines. Cancer Res 53: 5395-5400, 1993
8. Ladisch S, Kitada S and Hays E: Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest 79: 1879-1882, 1987.
9. Ladisch S, Sweeley CC, Becker H, and Gage D: Aberrant fatty acyl alpha-hydroxylation in human neuroblastoma tumor gangliosides. J Biol Chem 264: 12097-12105, 1989.
10. Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF and Hittelman WN Correlation of expression of H/ley/leb antigens with survival in patients with carcinoma of the lung. N Engl J Med 327: 14-18, 1992.
11. Hakamori S: Role of gangliosides in tumor progression. Progresses Brain Res 101: 241-250, 1994.
12. Ladisch S, Gillard B, Wong C and Ulsh L: Shedding and immunoregulatory activity of YAC-1 lymphoma cell ganglioside. Cancer Res 43: 3808-3813, 1983.
13. Bergelson LD, Dyatlovitskaya EV, Klyuchareva TE, Kryukova EV, Lemenovskaya AF, Matveeva VA, and Sinitsyna EV: The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells. Eur J Immunol 19: 1979-1983, 1989.
14. Ladisch S, Wu Z-L, Feig S, Ulsh L, Schwartz E, Floutsis G, Wiley F, Lenarsky C and Seeger R: Shedding of GD2 ganglioside by human neuroblastoma. Int J Cancer 39: 73-76, 1987.
15. Valentino L, Moss T, Olson E, Wang H-J, Elashoff R and Ladish S: Shed tumor gangliosides and progression of human neuroblastoma. Blood 75: 1564-1567, 1990.
16. Sietsma H, Nijhof W, Dontje B, Vellenga E, Kamps WA and Kok JW: Inhibition of hemopoiesis in vitro by neuroblastoma-derived gangliosides. Cancer Res 58: 4840-4844, 1998.
17. Sundaram SK, and Lev M: Inhibition of sphingolipid synthesis by cycloserin in vitro and in vivo. J Neurochem 42: 577-581, 1984.
18. Sundaram SK and Lev M: Inhibition of cerebrosides synthesis in the brains of mice treated with L-cycloserine. J Lipid Res 26: 473-477, 1985.
19. Sundaram SK and Lev M: The long term administration of L-cycloserine to mice; specific reduction of brain cerebroside levels. Neurochem Res 14: 41-44, 1989.
20. Mizrachi Y, Lev M, Harish Z, Sundaram SK and Rubinstein A: L-cycloserine, an inhibitor of sphingolipid biosynthesis, inhibits HIV-1 cytophatic effects, replication, and infectivity. J Acquir Immune Defic Syndr 7: 245-253, 1996.
21. Cinatl JJr, Cinatl J, Mainke M, Wei'Ωflog A, Steigmann G, Rabenau H, Doerr HW and Kornhuber B: Aphidicolin selectively kills neuroblastoma cells in vitro. Cancer Lett 67: 199-206, 1992.
22. Cinatl JJr, Cinatl J, Scholz M, Hernáiz Driever P, Henrich D, Kabickova H, Vogel JU, Doerr HW and Kornhuber B: Antituomor activity of sodium valproate in cultures of human neuroblastoma cells. Anti-Cancer Drugs 7: 766-773, 1996.
23. Cinatl JJr, Cinatl J, Vogel JU, Kotchetkov R, Hernaiz-Driever P, Kabickova H, Kornhuber B, Schwabe D and Doerr HW: Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res 58: 367-372, 1998.
24. Cinatl JJr, Cinatl J, Hernáiz Driever P, Kotchetkov R, Pouckova P, Kornhuber B and Schwabe D: Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anti-Cancer Drugs 8: 958-963, 1997.
25. Fredman P: Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors. Prog Brain Res 101: 225-240, 1994.
26. Akira O, Hiroo T, Kanchiro Y, Masaharu N, Hidenori M and Nobuhiko K: L-cycloserine amplifies antitumor activity of glutamine antagonist. J Clin Biochem Nutr 14: 53-60, 1993.
27. Radin NS: Chemotherapy by slowing glucosphingolipid synthesis. Biochem Pharmacol 57: 589-595, 1999.
28. Wu G, Ledeen W: Gangliosides as modulators of neuronal calcium. Prog Brain Rres 101: 101-112, 1994.
29. M2-rich cultures of a human glioma cell line. Cancer Res 51: 4643-4648, 1991.
30. Welt SW, Carswell EA, Vogel CV, Oettgen HF and Old LJ: Immune and non immune effector functions of IgG3 mouse monoclonal antibody R24 detecting the GD3 on the surface of melanoma cells. Clin Immunol Immunopathol 45: 214-229, 1987.